Vergoeding 2019-2023 voor ATC-subgroep L04AJ : Complement remmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
| L04AJ01 Eculizumab | 37.946.931 | 35.584.078 | 34.429.032 | 36.541.639 | 31.070.822 |
| L04AJ02 Ravulizumab | . | . | . | . | 7.058.589 |
| L04AJ04 Sutimlimab | . | . | . | . | 153.837 |
| Totaal | 37.946.931 | 35.584.078 | 34.429.032 | 36.541.639 | 38.283.248 |